Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cervical Cancer

  Free Subscription


Articles published in BMC Cancer

Retrieve available abstracts of 64 articles:
HTML format
Text format



Single Articles


    November 2017
  1. LI S, Wen X
    Seropositivity to herpes simplex virus type 2, but not type 1 is associated with cervical cancer: NHANES (1999-2014).
    BMC Cancer. 2017;17:726.
    PubMed     Text format     Abstract available


    October 2017
  2. HE S, Liao B, Deng Y, Su C, et al
    MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis.
    BMC Cancer. 2017;17:673.
    PubMed     Text format     Abstract available


    September 2017
  3. PARK S, Eom K, Kim J, Bang H, et al
    MiR-9, miR-21, and miR-155 as potential biomarkers for HPV positive and negative cervical cancer.
    BMC Cancer. 2017;17:658.
    PubMed     Text format     Abstract available


    August 2017
  4. BREBI P, Ili CG, Andana A, Menzel D, et al
    Frequency of Human papillomavirus in women attending cervical cancer screening program in Chile.
    BMC Cancer. 2017;17:518.
    PubMed     Text format     Abstract available


  5. LI J, Ning NY, Rao QX, Chen R, et al
    Pretreatment glycemic control status is an independent prognostic factor for cervical cancer patients receiving neoadjuvant chemotherapy for locally advanced disease.
    BMC Cancer. 2017;17:517.
    PubMed     Text format     Abstract available


  6. WANG W, Hou X, Yan J, Shen J, et al
    Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women.
    BMC Cancer. 2017;17:510.
    PubMed     Text format     Abstract available


    June 2017
  7. KARAGEORGOPOULOU S, Kostakis ID, Gazouli M, Markaki S, et al
    Prognostic and predictive factors in patients with metastatic or recurrent cervical cancer treated with platinum-based chemotherapy.
    BMC Cancer. 2017;17:451.
    PubMed     Text format     Abstract available


  8. BERRAHO M, Amarti-Riffi A, El-Mzibri M, Bezad R, et al
    HPV and cofactors for invasive cervical cancer in Morocco: a multicentre case-control study.
    BMC Cancer. 2017;17:435.
    PubMed     Text format     Abstract available


  9. XU Y, Zhu L, Liu B, Ru T, et al
    Strain elastography imaging for early detection and prediction of tumor response to concurrent chemo-radiotherapy in locally advanced cervical cancer: feasibility study.
    BMC Cancer. 2017;17:427.
    PubMed     Text format     Abstract available


  10. SUN XL, Wang HB, Wang ZQ, Cao TT, et al
    Effect of transcutaneous electrical stimulation treatment on lower urinary tract symptoms after class III radical hysterectomy in cervical cancer patients: study protocol for a multicentre, randomized controlled trial.
    BMC Cancer. 2017;17:416.
    PubMed     Text format     Abstract available


  11. HAYASHI N, Takahashi H, Hasegawa Y, Higuchi F, et al
    A nationwide multi-institutional retrospective study to identify prognostic factors and develop a graded prognostic assessment system for patients with brain metastases from uterine corpus and cervical cancer.
    BMC Cancer. 2017;17:397.
    PubMed     Text format     Abstract available


    April 2017
  12. KIM SW, Chun M, Ryu HS, Chang SJ, et al
    Long-term results of early adjuvant concurrent chemoradiotherapy for high-risk, early stage uterine cervical cancer patients after radical hysterectomy.
    BMC Cancer. 2017;17:297.
    PubMed     Text format     Abstract available


  13. WANG W, Li Y, Liu N, Gao Y, et al
    MiR-23b controls ALDH1A1 expression in cervical cancer stem cells.
    BMC Cancer. 2017;17:292.
    PubMed     Text format     Abstract available


  14. LI X
    Emerging role of mutations in epigenetic regulators including MLL2 derived from The Cancer Genome Atlas for cervical cancer.
    BMC Cancer. 2017;17:252.
    PubMed     Text format     Abstract available


    February 2017
  15. GAO ZW, Wang HP, Lin F, Wang X, et al
    CD73 promotes proliferation and migration of human cervical cancer cells independent of its enzyme activity.
    BMC Cancer. 2017;17:135.
    PubMed     Text format     Abstract available


  16. HONG D, Liu J, Hu Y, Lu X, et al
    Viral E6 is overexpressed via high viral load in invasive cervical cancer with episomal HPV16.
    BMC Cancer. 2017;17:136.
    PubMed     Text format     Abstract available


  17. DE FREITAS LM, Serafim RB, de Sousa JF, Moreira TF, et al
    Photodynamic therapy combined to cisplatin potentiates cell death responses of cervical cancer cells.
    BMC Cancer. 2017;17:123.
    PubMed     Text format     Abstract available


    January 2017
  18. GUERRERO-FLORES H, Apresa-Garcia T, Garay-Villar O, Sanchez-Perez A, et al
    A non-invasive tool for detecting cervical cancer odor by trained scent dogs.
    BMC Cancer. 2017;17:79.
    PubMed     Text format     Abstract available


    December 2016
  19. ZHANG X, Pan C, Zhou L, Cai Z, et al
    Knockdown of ST6Gal-I increases cisplatin sensitivity in cervical cancer cells.
    BMC Cancer. 2016;16:949.
    PubMed     Text format     Abstract available


    November 2016
  20. PAVLIDOU E, Daponte A, Egea R, Dardiotis E, et al
    Genetic polymorphisms of FAS and EVER genes in a Greek population and their susceptibility to cervical cancer: a case control study.
    BMC Cancer. 2016;16:923.
    PubMed     Text format     Abstract available


  21. HUIJSMANS CJ, Geurts-Giele WR, Leeijen C, Hazenberg HL, et al
    HPV Prevalence in the Dutch cervical cancer screening population (DuSC study): HPV testing using automated HC2, cobas and Aptima workflows.
    BMC Cancer. 2016;16:922.
    PubMed     Text format     Abstract available


  22. TRANBERG M, Bech BH, Blaakaer J, Jensen JS, et al
    Study protocol of the CHOiCE trial: a three-armed, randomized, controlled trial of home-based HPV self-sampling for non-participants in an organized cervical cancer screening program.
    BMC Cancer. 2016;16:835.
    PubMed     Text format     Abstract available


  23. STUQUI B, Conceicao AL, Termini L, Sichero L, et al
    The differential role of HTRA1 in HPV-positive and HPV-negative cervical cell line proliferation.
    BMC Cancer. 2016;16:840.
    PubMed     Text format     Abstract available


    October 2016
  24. WOODHEAD C, Cunningham R, Ashworth M, Barley E, et al
    Cervical and breast cancer screening uptake among women with serious mental illness: a data linkage study.
    BMC Cancer. 2016;16:819.
    PubMed     Text format     Abstract available


    February 2016
  25. KOENEMAN MM, Kruse AJ, Kooreman LF, Zur Hausen A, et al
    TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC trial): study protocol for a randomized controlled trial.
    BMC Cancer. 2016;16:132.
    PubMed     Text format     Abstract available


    January 2016
  26. LIU YJ, Zhang Q, Hu SY, Zhao FH, et al
    Effect of vaccination age on cost-effectiveness of human papillomavirus vaccination against cervical cancer in China.
    BMC Cancer. 2016;16:164.
    PubMed     Text format     Abstract available


  27. KARJALAINEN L, Anttila A, Nieminen P, Luostarinen T, et al
    Self-sampling in cervical cancer screening: comparison of a brush-based and a lavage-based cervicovaginal self-sampling device.
    BMC Cancer. 2016;16:221.
    PubMed     Text format     Abstract available


  28. PERALTA-ZARAGOZA O, Deas J, Meneses-Acosta A, De la O-Gomez F, et al
    Relevance of miR-21 in regulation of tumor suppressor gene PTEN in human cervical cancer cells.
    BMC Cancer. 2016;16:215.
    PubMed     Text format     Abstract available


  29. WAKATSUKI M, Kato S, Kiyohara H, Ohno T, et al
    The prognostic value of rectal invasion for stage IVA uterine cervical cancer treated with radiation therapy.
    BMC Cancer. 2016;16:244.
    PubMed     Text format     Abstract available


  30. TORRES-POVEDA K, Burguete-Garcia AI, Bahena-Roman M, Mendez-Martinez R, et al
    Risk allelic load in Th2 and Th3 cytokines genes as biomarker of susceptibility to HPV-16 positive cervical cancer: a case control study.
    BMC Cancer. 2016;16:330.
    PubMed     Text format     Abstract available


  31. CHOI CH, Chung JY, Chung EJ, Sears JD, et al
    Prognostic significance of annexin A2 and annexin A4 expression in patients with cervical cancer.
    BMC Cancer. 2016;16:448.
    PubMed     Text format     Abstract available


  32. MARCONI DG, Fregnani JH, Rossini RR, Netto AK, et al
    Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
    BMC Cancer. 2016;16:556.
    PubMed     Text format     Abstract available


  33. BAI H, Cao D, Yuan F, Wang H, et al
    Occult invasive cervical cancer after simple hysterectomy: a multi-center retrospective study of 89 cases.
    BMC Cancer. 2016;16:507.
    PubMed     Text format     Abstract available


  34. MURAKAMI N, Kato S, Nakano T, Uno T, et al
    A phase I/II clinical trial for the hybrid of intracavitary and interstitial brachytherapy for locally advanced cervical cancer.
    BMC Cancer. 2016;16:640.
    PubMed     Text format     Abstract available


  35. HIGAREDA-ALMARAZ JC, Ruiz-Moreno JS, Klimentova J, Barbieri D, et al
    Systems-level effects of ectopic galectin-7 reconstitution in cervical cancer and its microenvironment.
    BMC Cancer. 2016;16:680.
    PubMed     Text format     Abstract available


  36. CONSTANTINOU P, Dray-Spira R, Menvielle G
    Cervical and breast cancer screening participation for women with chronic conditions in France: results from a national health survey.
    BMC Cancer. 2016;16:255.
    PubMed     Text format     Abstract available


  37. CHUNG YL, Horng CF, Lee PI, Chen FL, et al
    Patterns of failure after use of (18)F-FDG PET/CT in integration of extended-field chemo-IMRT and 3D-brachytherapy plannings for advanced cervical cancers with extensive lymph node metastases.
    BMC Cancer. 2016;16:179.
    PubMed     Text format     Abstract available


  38. THARAVICHITKUL E, Lorvidhaya V, Kamnerdsupaphon P, Sukthomya V, et al
    Combined chemoradiation of cisplatin versus carboplatin in cervical carcinoma: a single institution experience from Thailand.
    BMC Cancer. 2016;16:501.
    PubMed     Text format     Abstract available


  39. LI L, Song X, Liu R, Li N, et al
    Chemotherapy versus radiotherapy for FIGO stages IB1 and IIA1 cervical carcinoma patients with postoperative isolated deep stromal invasion: a retrospective study.
    BMC Cancer. 2016;16:403.
    PubMed     Text format     Abstract available


  40. VOJTECHOVA Z, Sabol I, Salakova M, Smahelova J, et al
    Comparison of the miRNA profiles in HPV-positive and HPV-negative tonsillar tumors and a model system of human keratinocyte clones.
    BMC Cancer. 2016;16:382.
    PubMed     Text format     Abstract available


    March 2015
  41. JOZWIK M, Okungbowa OE, Lipska A, Jozwik M, et al
    Surface antigen expression on peripheral blood monocytes in women with gynecologic malignancies.
    BMC Cancer. 2015;15:129.
    PubMed     Text format     Abstract available


    January 2015
  42. KANG YJ, O'Connell DL, Lotocki R, Kliewer EV, et al
    Effect of changes in treatment practice on survival for cervical cancer: results from a population-based study in Manitoba, Canada.
    BMC Cancer. 2015;15:642.
    PubMed     Text format     Abstract available


  43. CHATTOPADHYAY K, Williamson AL, Hazra A, Dandara C, et al
    The combined risks of reduced or increased function variants in cell death pathway genes differentially influence cervical cancer risk and herpes simplex virus type 2 infection among black Africans and the Mixed Ancestry population of South Africa.
    BMC Cancer. 2015;15:680.
    PubMed     Text format     Abstract available


  44. HORIKAWA N, Baba T, Matsumura N, Murakami R, et al
    Genomic profile predicts the efficacy of neoadjuvant chemotherapy for cervical cancer patients.
    BMC Cancer. 2015;15:739.
    PubMed     Text format     Abstract available


  45. ZHANG W, Tian X, Mumtahana F, Jiao J, et al
    The existence of Th22, pure Th17 and Th1 cells in CIN and Cervical Cancer along with their frequency variation in different stages of cervical cancer.
    BMC Cancer. 2015;15:717.
    PubMed     Text format     Abstract available


  46. HOLMAN LL, Ren Y, Westin SN
    Status epilepticus associated with platinum chemotherapy in a patient with cervical cancer: a case report.
    BMC Cancer. 2015;15:728.
    PubMed     Text format     Abstract available


  47. WANG SM, Hu SY, Chen W, Chen F, et al
    Feasibility and accuracy evaluation of three human papillomavirus assays for FTA card-based sampling: a pilot study in cervical cancer screening.
    BMC Cancer. 2015;15:848.
    PubMed     Text format     Abstract available


  48. NGO C, Samuels S, Bagrintseva K, Slocker A, et al
    From prospective biobanking to precision medicine: BIO-RAIDs - an EU study protocol in cervical cancer.
    BMC Cancer. 2015;15:842.
    PubMed     Text format     Abstract available


  49. WANG YZ, Deng L, Xu HC, Zhang Y, et al
    Laparoscopy versus laparotomy for the management of early stage cervical cancer.
    BMC Cancer. 2015;15:928.
    PubMed     Text format     Abstract available


  50. COOK DA, Mei W, Smith LW, van Niekerk DJ, et al
    Comparison of the Roche cobas(R) 4800 and Digene Hybrid Capture(R) 2 HPV tests for primary cervical cancer screening in the HPV FOCAL trial.
    BMC Cancer. 2015;15:968.
    PubMed     Text format     Abstract available


  51. KIM BW, Cho H, Choi CH, Ylaya K, et al
    Clinical significance of OCT4 and SOX2 protein expression in cervical cancer.
    BMC Cancer. 2015;15:1015.
    PubMed     Text format     Abstract available


  52. SEIKI T, Nagasaka K, Kranjec C, Kawana K, et al
    HPV-16 impairs the subcellular distribution and levels of expression of protein phosphatase 1gamma in cervical malignancy.
    BMC Cancer. 2015;15:230.
    PubMed     Text format     Abstract available


  53. EJEGOD DM, Rebolj M, Bonde J
    Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample study.
    BMC Cancer. 2015;15:216.
    PubMed     Text format     Abstract available


  54. MENDES D, Bains I, Vanni T, Jit M, et al
    Systematic review of model-based cervical screening evaluations.
    BMC Cancer. 2015;15:334.
    PubMed     Text format     Abstract available


  55. NOWAKOWSKI A, Cybulski M, Sliwczynski A, Chil A, et al
    The implementation of an organised cervical screening programme in Poland: an analysis of the adherence to European guidelines.
    BMC Cancer. 2015;15:279.
    PubMed     Text format     Abstract available


  56. CHANG CC, Huang RL, Liao YP, Su PH, et al
    Concordance analysis of methylation biomarkers detection in self-collected and physician-collected samples in cervical neoplasm.
    BMC Cancer. 2015;15:418.
    PubMed     Text format     Abstract available


  57. ZHU L, Zhu L, Shi H, Wang H, et al
    Evaluating early response of cervical cancer under concurrent chemo-radiotherapy by intravoxel incoherent motion MR imaging.
    BMC Cancer. 2016;16:79.
    PubMed     Text format     Abstract available


  58. ZHAO YQ, Chang IJ, Zhao FH, Hu SY, et al
    Distribution of cervical intraepithelial neoplasia on the cervix in Chinese women: pooled analysis of 19 population based screening studies.
    BMC Cancer. 2015;15:485.
    PubMed     Text format     Abstract available


  59. CASTILHO JL, Levi JE, Luz PM, Cambou MC, et al
    A cross-sectional study of high-risk human papillomavirus clustering and cervical outcomes in HIV-infected women in Rio de Janeiro, Brazil.
    BMC Cancer. 2015;15:478.
    PubMed     Text format     Abstract available


  60. BATEMAN AC, Katundu K, Mwanahamuntu MH, Kapambwe S, et al
    The burden of cervical pre-cancer and cancer in HIV positive women in Zambia: a modeling study.
    BMC Cancer. 2015;15:541.
    PubMed     Text format     Abstract available


  61. ELLINGSEN C, Andersen LM, Galappathi K, Rofstad EK, et al
    Hypoxia biomarkers in squamous cell carcinoma of the uterine cervix.
    BMC Cancer. 2015;15:805.
    PubMed     Text format     Abstract available


  62. HOU T, Zhang W, Tong C, Kazobinka G, et al
    Putative stem cell markers in cervical squamous cell carcinoma are correlated with poor clinical outcome.
    BMC Cancer. 2015;15:785.
    PubMed     Text format     Abstract available


    October 2014
  63. NAGURA M, Koshiyama M, Matsumura N, Kido A, et al
    Clinical approaches to treating papillary squamous cell carcinoma of the uterine cervix.
    BMC Cancer. 2014;14:784.
    PubMed     Text format     Abstract available


  64. PINHEIRO C, Garcia EA, Morais-Santos F, Scapulatempo C, et al
    Lactate transporters and vascular factors in HPV-induced squamous cell carcinoma of the uterine cervix.
    BMC Cancer. 2014;14:751.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: